Cargando…

Immunoglobulines hyperimmunes anti-SARS-CoV-2, un choix stratégique urgent

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academie nationale de medecine 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234932/ https://www.ncbi.nlm.nih.gov/pubmed/32834024 http://dx.doi.org/10.1016/j.banm.2020.05.041

Ejemplares similares

Anti-SARS-CoV-2 hyperimmune immunoglobulins, an urgent strategic choice
Publicado: (2020)

Choix stratégiques et grands programmes civils
por: Cohendet, Patrick, et al.
Publicado: (1987)

L'analyse stratégique : comment concevoir les choix stratégiques en situation concurrentielle /
por: Garibaldi, Gérard
Publicado: (2001)

Anti-SARS-CoV-2 hyperimmune plasma workflow
por: Annamaria, Petrungaro, et al.
Publicado: (2020)

Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2
por: Burnouf, Thierry, et al.
Publicado: (2022)

Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma
por: Ali, Shaukat, et al.
Publicado: (2021)

The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19
por: Focosi, Daniele, et al.
Publicado: (2021)

Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern
por: Tang, Juanjie, et al.
Publicado: (2021)

Comparison of SARS-CoV-2 Hyperimmune Immunoglobulins Following Infection Plus Vaccination vs Infection
por: Bellusci, Lorenza, et al.
Publicado: (2023)

Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma
por: Vandeberg, Peter, et al.
Publicado: (2021)

Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants
por: Liu, Zhuoming, et al.
Publicado: (2021)

Hyperimmunized Chickens Produce Neutralizing Antibodies against SARS-CoV-2
por: Aston, Emily J., et al.
Publicado: (2022)

Immune Maturation Effects on Viral Neutralization and Avidity of Hyperimmunized Equine Anti-SARS-CoV-2 Sera
por: González Viacava, Myriam Belén, et al.
Publicado: (2022)

Gestion stratégique des connaissances
por: Rivard, Lucie, et al.
Publicado: (2002)

Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants
por: Bellusci, Lorenza, et al.
Publicado: (2023)

Potent Anti‐SARS‐CoV‐2 Efficacy of COVID‐19 Hyperimmune Globulin from Vaccine‐Immunized Plasma
por: Yu, Ding, et al.
Publicado: (2022)

There is an urgent need for safer anti-SARS-CoV-2 vaccines
por: Finsterer, Josef
Publicado: (2022)

Le nucléaire: un choix raisonnable ?
por: Nifenecker, Hervé
Publicado: (2011)

Analyse stratégique et avantage concurrentiel
por: Seni, Dan A
Publicado: (2012)

Human Intramuscular Hyperimmune Gamma Globulin (hIHGG) Anti-SARS-CoV-2—Characteristics of Intermediates and Final Product
por: Lachert, Elzbieta, et al.
Publicado: (2022)

Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial
por: Alemany, Andrea, et al.
Publicado: (2023)

High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern
por: Moreira-Soto, Andres, et al.
Publicado: (2021)

SARS‐CoV‐2 and lung injury: Dysregulation of immune response but not hyperimmune response as in “cytokine storm syndrome”
por: Öcal, Serpil
Publicado: (2021)

GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
por: Mizrahi, Rena A., et al.
Publicado: (2022)

WHO International Standard for anti-SARS-CoV-2 immunoglobulin
por: Kristiansen, Paul A, et al.
Publicado: (2021)

Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
por: Chavda, Vivek P., et al.
Publicado: (2023)

Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches
por: Stinca, Sara, et al.
Publicado: (2021)

Un choix sans équivoque : recherches historiques sur les relations amoureuses entre les femmes, XVIe-XXe siécle
por: Bonnet, Marie-Jo
Publicado: (1981)

SARS-CoV-2 Psychiatric Sequelae: An Urgent Need of Prevention
por: Bottemanne, Hugo, et al.
Publicado: (2021)

Le choix : essais /
por: Baillargeon, Pierre
Publicado: (1969)

ANTI-DNA ANTIBODIES IN HYPERIMMUNIZED RABBITS
por: Christian, Charles L., et al.
Publicado: (1965)

Cochrane corner: convalescent plasma or hyperimmune immunoglobulin for people with COVID-19
por: Nnaji, Chukwudi Arnest, et al.
Publicado: (2020)

La formation outil strategique du developpment economique territorial.
Publicado: (1990)

Nouveaux usages en santé, de réels impacts stratégiques
por: Mrozovski, Jean-Michel
Publicado: (2022)

Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation
por: Bihl, Florian, et al.
Publicado: (2010)

Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza
por: Vanderven, Hillary A., et al.
Publicado: (2023)

Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection
por: Li, Entao, et al.
Publicado: (2023)

Le schéma directeur des emplois et des ressources humaines: un outil de management stratégique
por: LeBoterf, Guy
Publicado: (1988)

Nuvaxovid, un nouveau vaccin anti-Sars-CoV-2
por: Manus, Jean-Marie
Publicado: (2022)

Choix de poémes /
por: Michaux, Henri, 1899-1984
Publicado: (1976)

Cannot write session to /tmp/vufind_sessions/sess_2cslsfnejv9vhttl22thjqopin